Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06549244 · ClinicalTrials.gov registry record
Preoperative Maximum Inspiratory Pressure and Outcomes After Interscalene Block in Obese Patients
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 45
- Enrollment target
NCT06549244: Completed study, sponsored by University of North Carolina, Chapel Hill.
NCT06549244 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 45 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06549244 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 45 participants
- Enrollment target
Study Summary
The study aims to explore if Maximum Inspiratory Pressure can predict postoperative breathlessness in obese patients receiving interscalene blocks for shoulder surgery. The main question is: does baseline Maximum Inspiratory Pressure have any association with postoperative breathlessness after interscalene blocks in class 2 or higher obese patients (BMI\>35). Preoperative and postoperative lung volumes, pressures, breathlessness score and respiratory outcomes will be measured on participants already receiving shoulder surgery with interscalene blocks.
Primary Outcome
Score of 3 or above on Modified Borg Breathlessness Scale
Interventions
- DIAGNOSTIC_TEST Maximum Inspiratory Pressure monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2023-07-01 |
| Est. Completion | 2024-01-10 |
What the finished NCT06549244 record still lists
NCT06549244 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 45 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Maximum Inspiratory Pressure monitoring is the first listed.
NCT06549244 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06549244 about?
NCT06549244 is a clinical study titled "Preoperative Maximum Inspiratory Pressure and Outcomes After Interscalene Block in Obese Patients". The study aims to explore if Maximum Inspiratory Pressure can predict postoperative breathlessness in obese patients receiving interscalene blocks for shoulder surgery. The main question is: does baseline Maximum Inspiratory Pressure have any association with postoperative breathlessness after inte...
What is the current status of trial NCT06549244?
This trial is currently completed. The enrollment target is 45 participants. The study started on 2023-07-01. Estimated completion is 2024-01-10.
What interventions are being tested in trial NCT06549244?
The interventions under investigation include: Maximum Inspiratory Pressure monitoring (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06549244?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI